Denali Capital Acquisition Corp., a blank check company listed on NASDAQ under the ticker DECA, has announced the mutual termination of its business combination agreement with Longevity Biomedical, Inc. This agreement was initially arranged to facilitate a merger, share exchange, asset acquisition, or similar business combination. Denali Capital’s press release emphasized forward-looking statements and the inherent risks and uncertainties, stressing no obligation to update such statements in the future. Both Denali and its sponsor are now seeking alternative pathways to complete an initial business combination.

Finance – SPAC, Healthcare – Biomedical,United States, Cayman Islands